New drug cocktail aims to shrink tonsil tumors before surgery

NCT ID NCT07353723

First seen Jan 23, 2026 · Last updated May 16, 2026 · Updated 20 times

Summary

This study tests whether giving a mix of two drugs (nimotuzumab and toripalimab) plus chemotherapy before surgery can help eliminate tonsil cancer cells in people with advanced disease. About 10 adults with resectable tonsil cancer will receive the treatment and then have surgery. The main goal is to see if no cancer remains in the removed tissue.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tangdu Hospital, Air Force Medical University, Xi'an 710038, Shaanxi Province, China

    RECRUITING

    Shanxi, Province, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.